Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Karl

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Genes, Brain, and Behavior|April 19, 2021
Behavioural effects of cage systems on the G93A Superoxide Dismutase 1 transgenic mouse model for amyotrophic lateral sclerosisStefan Guerra, Roger Chung, Justin Yerbury, et al.
Behavioural Brain Research|October 6, 2005
Effect of Y1 receptor deficiency on motor activity, exploration, and anxietyTim Karl, Thomas H J Burne, Herbert Herzog
Behavioural Brain Research|November 3, 2009
Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiencyTim Karl, Rose Chesworth, Liesl Duffy, et al.
Frontiers in Pharmacology|January 11, 2021
Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of <i>APP</i> <sub></sub> <i>/PS1ΔE9</i> Transgenic Female MiceMadilyn Coles, Georgia Watt, Fabian Kreilaus, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2026
Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibilityRose Chesworth, Georgia Watt, Erin McLemon, et al.
Behavioural Brain Research|February 24, 2022
Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic miceFabian Kreilaus, Magdalena Przybyla, Lars Ittner, et al.
Frontiers in Pharmacology|October 14, 2022
Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse modelRose Chesworth, David Cheng, Chloe Staub, et al.
Frontiers in Neuroscience|September 19, 2022
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's diseaseMadilyn Coles, Genevieve Z Steiner-Lim, Tim Karl
Physiology & Behavior|October 22, 2003
Extreme reduction of dipeptidyl peptidase IV activity in F344 rat substrains is associated with various behavioral differencesTim Karl, Torsten Hoffmann, Reinhard Pabst, et al.
Pharmacology, Biochemistry, and Behavior|September 6, 2003
Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activityTim Karl, Torsten Hoffmann, Reinhard Pabst, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Genes, Brain, and Behavior|April 19, 2021
Behavioural effects of cage systems on the G93A Superoxide Dismutase 1 transgenic mouse model for amyotrophic lateral sclerosisStefan Guerra, Roger Chung, Justin Yerbury, et al.
Behavioural Brain Research|October 6, 2005
Effect of Y1 receptor deficiency on motor activity, exploration, and anxietyTim Karl, Thomas H J Burne, Herbert Herzog
Behavioural Brain Research|November 3, 2009
Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiencyTim Karl, Rose Chesworth, Liesl Duffy, et al.
Frontiers in Pharmacology|January 11, 2021
Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of <i>APP</i> <sub></sub> <i>/PS1ΔE9</i> Transgenic Female MiceMadilyn Coles, Georgia Watt, Fabian Kreilaus, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 25, 2026
Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibilityRose Chesworth, Georgia Watt, Erin McLemon, et al.
Behavioural Brain Research|February 24, 2022
Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic miceFabian Kreilaus, Magdalena Przybyla, Lars Ittner, et al.
Frontiers in Pharmacology|October 14, 2022
Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse modelRose Chesworth, David Cheng, Chloe Staub, et al.
Frontiers in Neuroscience|September 19, 2022
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's diseaseMadilyn Coles, Genevieve Z Steiner-Lim, Tim Karl
Physiology & Behavior|October 22, 2003
Extreme reduction of dipeptidyl peptidase IV activity in F344 rat substrains is associated with various behavioral differencesTim Karl, Torsten Hoffmann, Reinhard Pabst, et al.
Pharmacology, Biochemistry, and Behavior|September 6, 2003
Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activityTim Karl, Torsten Hoffmann, Reinhard Pabst, et al.
Pageof 13